Nadia Waheed
CIK 2023884 · Chief Medical Officer · last filed 2026-06-05
Nadia Waheed is a Chief Medical Officer who has filed 8 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing shows the insider sold $122.6K of OCUL on Jun 5, 2026. Across all open-market trades the lifetime net is −$332.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.49M
1
8
-$332.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OCUL | Chief Medical Officer | 300,079 | $8.29 | $2.49M | -$332.5K | 8 | 2026-06-05 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | OCUL | Sell (S) | −14,828 | -$122.6K | EDGAR |
| 2026-02-24 | OCUL | Sell (S) | −3,510 | -$27.2K | EDGAR |
| 2026-02-17 | OCUL | Sell (S) | −7,863 | -$71.1K | EDGAR |
| 2026-01-06 | OCUL | Grant (A) | +79,112 | $0 | EDGAR |
| 2025-08-14 | OCUL | Grant (A) | +40,363 | $0 | EDGAR |
| 2025-06-03 | OCUL | Sell (S) | −13,861 | -$111.6K | EDGAR |
| 2025-02-13 | OCUL | Grant (A) | +79,000 | $0 | EDGAR |
| 2024-06-04 | OCUL | Grant (A) | +141,666 | $0 | EDGAR |